Prevalence of the Ser217Leu Variant of the ELAC2 Gene and Its Association with Prostate Cancer in Population of the Littoral Region of Cameroon

<p>Agarose gel electrophoregram of ELAC2 gene amplified by touchdown PCR from participants’ genomic DNA extracts. Lane M = 100bp molecular weight marker and lane 50-54 = DNA amplicons of participants. Numbers represent participants’ codes.</p>

Prostate Cancer

fig2

Figure 2

Figure 2: Prevalence of the Ser217Leu Variant of the ELAC2 Gene and Its Association with Prostate Cancer in Population of the Littoral Region of Cameroon 

Figure 2 | Prevalence of the Ser217Leu Variant of the ELAC2 Gene and Its Association with Prostate Cancer in Population of the Littoral Region of Cameroon 